Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The sympathetic nervous system in the 21st century: Neuroimmune interactions in metabolic homeostasis and obesity

Martinez-Sanchez N., Sweeney O., Sidarta-Oliveira D., Caron A., Stanley SA., Domingos AI.

Narrative Review on Immune Modulation, published in Neuron (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Neuron (2022)
Reported sample size
—
Source database
Europe PMC
PMID
36327900
PMCID
PMC9986959
DOI
10.1016/j.neuron.2022.10.017
Citations
93

Abstract (original English)

The sympathetic nervous system maintains metabolic homeostasis by orchestrating the activity of organs such as the pancreas, liver, and white and brown adipose tissues. From the first renderings by Thomas Willis to contemporary techniques for visualization, tracing, and functional probing of axonal arborizations within organs, our understanding of the sympathetic nervous system has started to grow beyond classical models. In the present review, we outline the evolution of these findings and provide updated neuroanatomical maps of sympathetic innervation. We offer an autonomic framework for the neuroendocrine loop of leptin action, and we discuss the role of immune cells in regulating sympathetic terminals and metabolism. We highlight potential anti-obesity therapeutic approaches that emerge from the modern appreciation of SNS as a neural network vis a vis the historical fear of sympathomimetic pharmacology, while shifting focus from post- to pre-synaptic targeting. Finally, we critically appraise the field and where it needs to go.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Sympathetic Nervous SystemHumansObesityNeuroimmunomodulationHomeostasisAdipose Tissue, Brown

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research